Year founded
-
Country of origin
Canada
HQ country
Canada
Total deal value
Average deal value
Company industry
- Healthcare & Pharmaceuticals
M&A expertise
- -
Industry expertise
- Healthcare & Pharmaceuticals
Valeant Pharmaceuticals International, Inc. (NYSE/TSX: VRX) founded in 1960, is a multinational specialty pharmaceutical and medical device company that develops, manufactures and markets a broad range of prescription and non-prescription pharmaceutical products that make a meaningful difference in patients’ lives throughout more than 100 countries. Valeant’s primary focus is in the areas of dermatology and eye health.
Latest deals
Pharming acquires rights for its own drug Ruconest from Valeant
09-08-2016
€ 100 - 250 million